Managing diabetes during pregnancy with insulin lispro: A safe alternative to human insulin

Endocrine Practice

Volumn 16, Issue 6, 2010, Pages 1020-1027

  Edson, Emily J ^a   Bracco, Oswaldo L ^a   Vambergue, Anne ^b   Koivisto, Veikko ^c  

^a ELI LILLY AND COMPANY   (United States)

^b UNIV LILLE   (France)

^c LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN LISPRO;

ADVERSE OUTCOME; BIRTH WEIGHT; CESAREAN SECTION; CLINICAL ASSESSMENT; CONGENITAL MALFORMATION; DIABETES CONTROL; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL HYPERTENSION; MEDLINE; NEWBORN MORTALITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW;

DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; UNITED STATES;

EID: 79952391285     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10003.RA     Document Type: Review

References (46)

1. Singh C, Jovanovic L. Insulin analogues in the treatment of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34:275-291, ix.
2. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427. (Pubitemid 29418233)
3. Aydin Y, Berker D, Direktör N, et al. Is insulin lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers? Diabetes Res Clin Pract. 2008;80:444-448.
4. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med. 2008;21:309-313. (Pubitemid 351652520)
5. Lapolla A, Dalfrà MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol. 2008;45:61-66.
6. Wyatt JW, Frias JL, Hoyme HE, et al (IONS Study Group). Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med. 2005;22:803-807. (Pubitemid 40805905)
7. Carr KJ, Idama TO, Masson EA, Ellis K, Lindow SW. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes - the effect on glycaemic excursion. J Obstet Gynaecol. 2004;24:382-386. (Pubitemid 38824088)
8. Cypryk K, Sobczak M, Pertyńska-Marczewska M, et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. Med Sci Monit. 2004;10:PI29-PI32.
9. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
10. Garg SK, Frias JP, Anil S, Gottlieb PA, MacKenzie T, Jackson WE. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocr Pract. 2003;9:187-193.
11. Masson EA, Patmore JE, Brash PD, et al. Pregnancy outcome in type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabet Med. 2003;20:46-50. (Pubitemid 36104202)
12. Persson B, Swahn ML, Hjertberg R, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract. 2002;58:115-121.
13. Scherbaum WA, Lankisch MR, Pawlowski B, Somville T. Insulin lispro in pregnancy - retrospective analysis of 33 cases and matched controls. Exp Clin Endocrinol Diabetes. 2002;110:6-9. (Pubitemid 34136275)
14. Bhattacharyya A, Brown S, Hughes S, Vice PA. Insulin lispro and regular insulin in pregnancy. QJM. 2001;94:255-260. (Pubitemid 32492747)
15. Idama TO, Lindow SW, French M, Masson EA. Preliminary experience with the use of insulin lispro in pregnant diabetic women. J Obstet Gynaecol. 2002;21:350-351.
16. Dolci M, Mori M, Baccetti F. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's disease. Diabetes Care. 2005;28:2084-2085. (Pubitemid 41061000)
17. Stechova K, Bartaskova D, Mrstinova M, et al. Pregnancy in a woman suffering from type 1 diabetes associated with Addison's disease and Hashimoto's thyroiditis (fully developed autoimmune polyglandular syndrome type 2). Exp Clin Endocrinol Diabetes. 2004;112:333-337. (Pubitemid 38849845)
18. Durand-Gonzalez K, Guillausseau N, Anciaux ML, Hentschel V, Gayno JP. Allergy to insulin in a woman with gestational diabetes mellitus: transient efficiency of continuous subcutaneous insulin lispro infusion. Diabetes Metab. 2003;29(4, pt 1):432-434. (Pubitemid 37187113)
19. Devlin JT, Hothersall L, Wilkis JL. Use of insulin glargine during pregnancy in a type 1 diabetic woman. Diabetes Care. 2002;25:1095-1096.
20. Anderson JH Jr, Bastyr EJ III, Wishner KL. Possible adverse fetal effect of insulin lispro [letter]. N Engl J Med. 1997;337:1010.
21. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro [letter]. N Engl J Med. 1997;337:1009.
22. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: The Diabetes in Early Pregnancy Study; National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631-637.
23. Jovanovic-Peterson L, Peterson CM. Diabetic retinopathy. Clin Obstet Gynecol. 1991;34:516-525.
24. Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy [letter]. Diabetes Care. 1999;22:874-876. (Pubitemid 29220811)
25. Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy. Diabetes Care. 1999;22:2101-2104. (Pubitemid 30434010)
26. Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol. 2000;183:1162-1165.
27. Loukovaara S, Immonen I, Teramo KA, Kaaja R. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro. Diabetes Care. 2003;26:1193-1198. (Pubitemid 36929271)
28. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191:964-968. (Pubitemid 39298142)
29. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32:2005-2009.
30. Di Cianni G, Volpe L, Ghio A, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin. Diabetes Care. 2007;30:e11. (Pubitemid 46556613)
31. Mecacci F, Carignani L, Cioni R, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur J Obstet Gynecol Reprod Biol. 2003;111:19-24. (Pubitemid 37230061)
32. Mello G, Parretti E, Mecacci F, et al. What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in fullterm infants? Diabetes Care. 2000;23:1494-1498.
33. Boskovic R, Feig DS, Derewlany L, Knie B, Portnol G, Koren G. Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care. 2003;26:1390-1394. (Pubitemid 36929168)
34. Holcberg G, Tsadkin-Tamir M, Sapir O, et al. Transfer of insulin lispro across the human placenta. Eur J Obstet Gynecol Reprod Biol. 2004;115:117-118. (Pubitemid 38844235)
35. March of Dimes. PeriStats: your online source for perinatal statistics. http://www.marchofdimes.com/peristats. Accessed for verification October 12, 2010.
36. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. http://www.cdc.gov/diabetes/pubs/pdf/ndfs- 2007.pdf. Accessed for verification October 12, 2010.
37. Torlone E, Di Cianni G, Mannino D, Lapolla A. Insulin analogs and pregnancy: an update. Acta Diabetol. 2009;46:163-172.
38. Mathiesen ER, Kinsley B, Amiel SA, et al (Insulin Aspart Pregnancy Study Group). Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30:771-776. (Pubitemid 46556565)
39. Pettitt DJ, Ospina P, Howard C, Zisser H, Jovanovic L. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med. 2007;24:1129-1135. (Pubitemid 47437887)
40. Hod M, Damm P, Kaaja R, et al (Insulin Aspart Pregnancy Study Group). Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;1982:186e1-7.
41. Price N, Bartelett C, Gilmer M. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG. 2007;114:453-457. (Pubitemid 46393280)
42. Pöyhönen-Alho M, Rönnemaa T, Saltevo J, Ekblad U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand. 2007;Aug 29:1-4.
43. Tahrani AA, Varughese G, Wilkins JD, Taylor SE, Hanna FW. Glargine in pregnant patients with type 1 diabetes. Diabet Med. 2008;25:111-112.
44. Imbergamo MP, Amato MC, Sciortino G, et al. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther. 2008;30:1476-1484.
45. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med. 2008;25:165-169. (Pubitemid 351293402)
46. Di Cianni G, Torlone E, Lencioni C, et al (Italian Diabetes and Pregnancy Study Group; Italian Society of Diabetology). Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med. 2008;25:993-996.